D
Dagfinn Albrechtsen
Researcher at Finnish Red Cross
Publications - 62
Citations - 3058
Dagfinn Albrechtsen is an academic researcher from Finnish Red Cross. The author has contributed to research in topics: Transplantation & Kidney transplantation. The author has an hindex of 24, co-authored 62 publications receiving 3034 citations.
Papers
More filters
Journal Article
Placebo-controlled study of mycophenolate mofetil combined with cyclosporine and corticosteroids for prevention of acute rejection
Josep M. Grinyó,Carl-Gustav Groth,Rudolf Pichlmayr,Sa Sadek,Yves Vanrenterghem,M Behrend,R Luck,Francesc Moreso,J Peeters,J Rodicio,J Morales,Dagfinn Albrechtsen,P Fauchald,Sameh S. Sadek,J. P. A. Lodge,Jp Soulillou,Diego Cantarovich,van Willem Son,Adam Tegzess,Karl-Heinz Wagner,J Erhard,Christina Brattström,Lars Mjörnstedt,M. Wiesel,S. Carl,Hh Neumayer,Hauser,Peter Lang,B Bourgeon,Gunnar Tufveson,G. Gannedahl,Henrik Ekberg,N. Persson,A Tarantino,M Campise,G Thiel,M Zeiler,R Hene,G Ligtenberg,A Morgan,K Rigg,Hooftman L,K Hutchinson +42 more
TL;DR: MMF significantly reduced the rate of biopsy-proven rejection or other treatment failure during the first 6 months after transplantation and was well tolerated, although the 3 g dose was somewhat less well tolerated.
Journal ArticleDOI
Ischemic heart disease--major cause of death and graft loss after renal transplantation in Scandinavia.
TL;DR: It is concluded that Scandinavian renal transplant recipients are at high risk of dying of HID, and future advances in long-term renal graft survival will depend largely on the success of preventing myocardial infarction and death in this patient population.
Journal ArticleDOI
The impact of acute rejection episodes on long-term graft function and outcome in 1347 primary renal transplants treated by 3 cyclosporine regimens.
TL;DR: Although the incidence of first acute rejection was similar in CD and LD patients, it was successfully reversed by antirejection treatment in a higher percentage in LD patients and the estimated graft half-life was shorter in patients who had acute rejection episodes than those who did not.
Journal Article
Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial
M Behrend,J. M. Grinyo,Y. Vanrenterghem,J Rodicio,Dagfinn Albrechtsen,Sameh S. Sadek,Jean-Paul Soulillou,W van Son,Carl-Gustav Groth,Lars Mjörnstedt,M Wiesel,H.-H. Neumayer,Gunnar Tufveson,Henrik Ekberg,A Tarantino,G Thiel,Ronald J. Hené,A Morgan,Ramos El,M Rees +19 more
TL;DR: Analysis of 3-year data for patient and graft survival, and safety in the MMF-treated patients indicates that MMF treatment not only results in a reduction of the incidence of acute rejections but also leads to reduction of late allograft loss.
Journal ArticleDOI
Depletion of T lymphocytes from human bone marrow: use of magnetic monosized polymer microspheres coated with T-lymphocyte-specific monoclonal antibodies
Frode Vartdal,Gunnar Kvalheim,Tor Lea,Vidar Bosnes,Gustav Gaudernack,John Ugelstad,Dagfinn Albrechtsen +6 more
TL;DR: The T cell depletion procedure provided a 43–74% recovery of non-T cells present in the Isopaque-Ficoll-isolated bone marrow mononuclear cell fraction and did not disturb the growth potential of stem cells, as assayed by hematopoietic stem cell assays.